Abstract
43735 Safety and Tolerability of a single 5-day Treatment Cycle of Tirbanibulin Ointment 1% in Large Field (100cm2): A phase I Trial in patients with Actinic Keratosis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
